恒瑞医药港股上市募资近百亿 实控人孙飘扬夫妇传奇再续

DoNews
23 May

5月23日,恒瑞医药在港交所上市,发行价44.05港元,募资净额97.47亿港元。公司开盘价57港元,较发行价上涨29%,市值约3764亿港元。恒瑞医药2024年营收279.85亿元,同比增长22.63%;净利63.37亿元,增长47.28%。实控人孙飘扬通过江苏恒瑞医药集团持股23.3%,其妻钟慧娟曾带领翰森制药港股上市,二人被誉为中国最牛医药夫妻档。免责声明:本文内容由开放的智能模型自动生成,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10